Whether chemotherapy is needed for one year of chemotherapy for elderly acute myeloid leukemia depends on the effect of chemotherapy, the condition of cancer cells in the body, etc. Generally, patients need consolidation and intensive chemotherapy for a period of time. Elderly AML patients usually need induction chemotherapy to achieve remission, and after complete remission, maintenance consolidation chemotherapy and intensive chemotherapy are still needed in the later stage. Therefore, after 1 year of chemotherapy, the decision to continue chemotherapy should be made according to the situation. After chemotherapy, bone marrow aspiration is needed to check the situation of malignant cells in the blood, and according to the examination results, a corresponding chemotherapy plan should be formulated. If the cancer cells have disappeared, chemotherapy can be suspended according to the doctor’s suggestion; if the cancer cells have been reduced but the immune residuals are still positive, chemotherapy should be continued, and if the patient doesn’t continue the chemotherapy, the malignant cells may grow again, and there is a possibility that the disease may recur in the short term. Specific drugs include cytarabine, azacitidine, and vinacrine. Elderly acute myeloid leukemia is recommended to undergo standardized treatment under the guidance of specialists with a view to obtaining a good prognosis.